ARTICLE | Clinical News
Macrilen macimorelin acetate regulatory update
November 24, 2014 8:00 AM UTC
FDA issued a complete response letter for Macrilen macimorelin from Aeterna Zentaris for use in evaluating adult growth hormone deficiency (AGHD). According to Aeterna Zentaris, FDA said the company’s...